Research and experimental development on natural sciences and engineering
EPIDEMI AS
Revenue 2025
NOK 36,000
Operating profit
NOK −10,000
Equity
NOK −84,000
Incorporated
2012
Share capital
NOK 100,000
Financials
Total operating revenue
Operating profit (EBIT)
Income statement
| Post | 2025 | Trend |
|---|---|---|
| Total operating revenue | 36k | |
| Total operating costs | 46k | |
| Operating profit (EBIT) | −10k | |
| Net financial items | −67 | |
| Profit for the year | −10k |
Balance sheet
| Post | 2025 | Trend |
|---|---|---|
| Total assets | 10k | |
| of which current assets | 10k | |
| Equity | −84k | |
| Total liabilities | 94k |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.